Kildal Daniela, Braunschweig Rainer, Schaal Matthias, Mack Martin
Spitalzentrum Oberwallis, Pflanzettastr. 8, 3930, Visp, Schweiz.
Max Grundig Klinik GmbH, Schwarzwaldhochstraße 1, 77815, Bühl, Deutschland.
Radiologe. 2021 Dec;61(12):1096-1106. doi: 10.1007/s00117-021-00930-3. Epub 2021 Nov 4.
CLINICAL/METHODICAL ISSUE: Diagnosis of sclerosing and hyperostotic bone disorders (SHS) is challenging. The correct and early identification of SHS can have therapeutic, prognostic and, in case of genetic SHS with regard to the risk of inheritance, advisory consequences.
For diagnosis, radiographic examinations and supplementary computed tomography (CT) and magnetic resonance imaging (MRI) are used. These are of indicative nature. Definitive diagnosis is usually made by genetic differentiation.
In combination with the age of the affected person and the location of the osseous changes the characteristic image criteria are important. These are summarized in groups in this overview.
Projection radiography in two planes is the imaging modality of choice. CT and MR can detect additional differential diagnostic criteria and should be indicated when needed.